GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue (Q28373869)

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Pharmacology of nicotine: addiction and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

A study of the occurrence of anabaseine in Paranemertes and other nemertines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

C.N.S. effect of nicotine as the discriminative stimulus for the rat in a T-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Role of training dose in discrimination of nicotine and related compounds by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

The scientific case that nicotine is addictive.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

Response acquisition with fixed and variable resetting delays of reinforcement in male and female Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900054-4

7 January 2021

10.1016/S0091-3057(99)00054-4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10515327

1 reference

Consolidated OpenCitations Corpus – April 2017